Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TBI

K-Number: K232669 · 2023-09-29

Decision Date2023-09-29
Product CodeQAT
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

TBI is a medical device manufactured by Abbott Laboratories. It received FDA 510(k) clearance on 2023-09-29 under approval number K232669. The device is classified under product code QAT. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TBI?

TBI is a medical device that received FDA 510(k) clearance on 2023-09-29. It is manufactured by Abbott Laboratories. The 510(k) number is K232669.

When was TBI approved by the FDA?

TBI received FDA 510(k) clearance on 2023-09-29, under approval number K232669.

What company makes TBI?

TBI is manufactured by Abbott Laboratories.

What is the FDA product code for TBI?

The FDA product code for TBI is QAT.

Other Devices by Abbott Laboratories

View all 34 devices →

Related Devices (Code: QAT)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.